In SPINK1-positive prostate cancer cells, forced ectopic expression of miR-338-5p and miR-421 eliminated tumorigenic properties, including cell cycle progression, stem cell resistance and drug resistance, and the miR-338-5p/-421/SPINK1 pathway may be a valuable target for tumor therapy (46, 47). The gene discussed is SPINK1; the disease is neoplasm.